David Roth's Net Worth
$208 Thousand
Who is David Roth?
David Roth does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Syros Pharmaceuticals, Inc., INFINITY PHARMACEUTICALS, INC., and Allarity Therapeutics, Inc..
SEC CIK
David Roth's CIK is 0001599014
Past Insider Trading and Trends
2022 was David Roth's most active year for acquiring shares with 5 total transactions. David Roth's most active month to acquire stocks was the month of January. 2023 was David Roth's most active year for disposing of shares, totalling 7 transactions. David Roth's most active month to dispose stocks was the month of March. 2022 saw David Roth paying a total of $0.00 for 492,500 shares, this is the most they've acquired in one year. In 2024 David Roth cashed out on 30,666 shares for a total of $76,707.33, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Syros Pharmaceuticals, Inc. (SYRS) Snapshot price: $1.6
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 12.1K |
$2.09 | -$14,161.84 | 12.1K |
Oct 31
| |||
Form 4
| -100.00% | -10.45K |
$4.95 | -$51,732.45 |
0
|
Apr 3
| |||
Form 4
|
∞
| 10.45K |
$5.12 | -$24,974.88 | 10.45K |
Mar 31 - Apr 2
| |||
Form 4
| -100.00% | -6.29K |
$4.95 | -$31,120.65 |
0
|
Dec 12
| |||
Form 4
| -50.00% | -6.29K |
$3.95 | -$24,833.65 | 6.29K |
Dec 6
| |||
Form 4
|
∞
| 12.57K |
$2.22 | -$13,988.22 | 12.57K |
Oct 31 - Nov 1
| |||
Form 4
| -100.00% | -7.35K |
$3.95 | -$29,024.60 |
0
|
Jul 31
| |||
Form 4
| +23.06% | 1.38K |
$2.58 | -$1,607.34 | 7.35K |
Mar 31 - Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 4
| -31.36% | -27.28K |
$1.12 | -$30,554.72 | 59.72K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
∞
| 87K |
—
|
—
| 87K |
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INFINITY PHARMACEUTICALS, INC. (INFIQ) Snapshot price: $0.000001
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Allarity Therapeutics, Inc. (ALLR) Snapshot price: $0.165
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||